TreeWAS
Search
Variant clusters
Hospitalization Episode Statistics (HES)
Genetic variants: 36,212
Diagnostic terms: × 19,155
Association results: = 693,640,860
Self-Reported Statistics (SRS)
Genetic variants: 28,458
Diagnostic terms: × 474
Association results: = 13,489,092
About
Frequently Asked Questions
Citation
Download association data
for this variant in csv format
Share this page

Variant-specific associations

rs9304270
log Bayes Factor = 1.42842
Chromosome 18   position 39,937,509  (GRCh37) Explore rs9304270 on Ensembl!
Variant rs9304270 is listed in the   GWAS Catalog   ⇪

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)
Hierarchical visualisation How to interpret this figure?
Associations at terminal nodes are shown if p(effect) ≥
Click here to show this figure without filtering.
Click on a node to zoom (except terminal nodes).
Download this figure in format
Results table
Term Risk
posterior probability
 No effect
posterior probability
 Protective
posterior probability
  
T36-T50 Poisoning by drugs, medicaments and biological substances
0.000 0.035 0.965
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]
0.000 0.040 0.960
T43 Poisoning by psychotropic drugs, not elsewhere classified
0.000 0.042 0.958
T40.2 Other opioids
0.000 0.043 0.957
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics
0.000 0.081 0.919
T43.5 Other and unspecified antipsychotics and neuroleptics
0.000 0.103 0.897
T43.0 Tricyclic and tetracyclic antidepressants
0.000 0.107 0.893
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs
0.000 0.110 0.890
T46 Poisoning by agents primarily affecting the cardiovascular system
0.000 0.119 0.881
T39.1 4-Aminophenol derivatives
0.000 0.140 0.860
T44 Poisoning by drugs primarily affecting the autonomic nervous system
0.000 0.145 0.855
T43.3 Phenothiazine antipsychotics and neuroleptics
0.000 0.149 0.851
T42.4 Benzodiazepines
0.000 0.151 0.849
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]
0.000 0.207 0.793
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified
0.000 0.224 0.776
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs
0.000 0.233 0.767
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified
0.000 0.251 0.749
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified
0.000 0.259 0.741
T43.2 Other and unspecified antidepressants
0.000 0.265 0.735
T46.1 Calcium-channel blockers
0.000 0.293 0.707
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs
0.000 0.308 0.692
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system
0.000 0.308 0.692
T47 Poisoning by agents primarily affecting gastro-intestinal system
0.000 0.308 0.692
T41 Poisoning by anaesthetics and therapeutic gases
0.000 0.308 0.692
T37 Poisoning by other systemic anti-infectives and antiparasitics
0.000 0.308 0.692
T46.4 Angiotensin-converting-enzyme inhibitors
0.000 0.308 0.691
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances
0.000 0.310 0.690
T40.9 Other and unspecified psychodysleptics [hallucinogens]
0.000 0.312 0.688
T40.8 Lysergide [LSD]
0.000 0.312 0.688
T40.7 Cannabis (derivatives)
0.000 0.312 0.688
T40.5 Cocaine
0.000 0.312 0.688
T40.3 Methadone
0.000 0.312 0.688
T40.1 Heroin
0.000 0.312 0.688
T40.0 Opium
0.000 0.312 0.688
T43.9 Psychotropic drug, unspecified
0.000 0.313 0.687
T43.8 Other psychotropic drugs, not elsewhere classified
0.000 0.313 0.687
T43.4 Butyrophenone and thioxanthene neuroleptics
0.000 0.313 0.687
T43.1 Monoamine-oxidase-inhibitor antidepressants
0.000 0.313 0.687
T43.6 Psychostimulants with abuse potential
0.000 0.326 0.674
T40.6 Other and unspecified narcotics
0.000 0.337 0.663
T40.4 Other synthetic narcotics
0.000 0.340 0.659
T39.4 Antirheumatics, not elsewhere classified
0.000 0.341 0.659
T39.2 Pyrazolone derivatives
0.000 0.341 0.659
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants
0.000 0.362 0.638
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified
0.000 0.362 0.638
T42.5 Mixed antiepileptics, not elsewhere classified
0.000 0.362 0.638
T42.3 Barbiturates
0.000 0.362 0.638
T42.2 Succinimides and oxazolidinediones
0.000 0.362 0.638
T42.1 Iminostilbenes
0.000 0.362 0.638
T46.9 Other and unspecified agents primarily affecting the cardiovascular system
0.000 0.368 0.632
T46.8 Antivaricose drugs, including sclerosing agents
0.000 0.368 0.632
T46.7 Peripheral vasodilators
0.000 0.368 0.632
T46.5 Other antihypertensive drugs, not elsewhere classified
0.000 0.368 0.632
T46.3 Coronary vasodilators, not elsewhere classified
0.000 0.368 0.632
T46.2 Other antidysrhythmic drugs, not elsewhere classified
0.000 0.368 0.632
T46.0 Cardiac-stimulant glycosides and drugs of similar action
0.000 0.368 0.632
T36 Poisoning by systemic antibiotics
0.000 0.374 0.626
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs
0.000 0.380 0.619
T42.0 Hydantoin derivatives
0.000 0.384 0.616
T44.9 Other and unspecified drugs primarily affecting the nervous system
0.000 0.387 0.613
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified
0.000 0.387 0.613
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified
0.000 0.387 0.613
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified
0.000 0.387 0.613
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified
0.000 0.387 0.613
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified
0.000 0.387 0.613
T44.2 Ganglionic blocking drugs, not elsewhere classified
0.000 0.387 0.613
T44.1 Other parasympathomimetics [cholinergics]
0.000 0.387 0.613
T44.0 Anticholinesterase agents
0.000 0.387 0.613
T42.6 Other antiepileptic and sedative-hypnotic drugs
0.000 0.413 0.587
T39.0 Salicylates
0.000 0.416 0.583
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified
0.000 0.431 0.569
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified
0.000 0.431 0.569
T50.9 Other and unspecified drugs, medicaments and biological substances
0.000 0.467 0.532
T38.9 Other and unspecified hormone antagonists
0.000 0.468 0.531
T38.8 Other and unspecified hormones and their synthetic substitutes
0.000 0.468 0.531
T38.7 Androgens and anabolic congeners
0.000 0.468 0.531
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified
0.000 0.468 0.531
T38.5 Other oestrogens and progestogens
0.000 0.468 0.531
T38.4 Oral contraceptives
0.000 0.468 0.531
T38.2 Antithyroid drugs
0.000 0.468 0.531
T38.0 Glucocorticoids and synthetic analogues
0.000 0.468 0.531
T37.9 Systemic anti-infective and antiparasitic, unspecified
0.000 0.504 0.496
T37.8 Other specified systemic anti-infectives and antiparasitics
0.000 0.504 0.496
T37.5 Antiviral drugs
0.000 0.504 0.496
T37.4 Anthelminthics
0.000 0.504 0.496
T37.3 Other antiprotozoal drugs
0.000 0.504 0.496
T37.2 Antimalarials and drugs acting on other blood protozoa
0.000 0.504 0.496
T37.1 Antimycobacterial drugs
0.000 0.504 0.496
T37.0 Sulphonamides
0.000 0.504 0.496
T41.5 Therapeutic gases
0.000 0.504 0.496
T41.4 Anaesthetic, unspecified
0.000 0.504 0.496
T41.3 Local anaesthetics
0.000 0.504 0.496
T41.2 Other and unspecified general anaesthetics
0.000 0.504 0.496
T41.1 Intravenous anaesthetics
0.000 0.504 0.496
T41.0 Inhaled anaesthetics
0.000 0.504 0.496
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified
0.000 0.504 0.496
T47.8 Other agents primarily affecting the gastro-intestinal system
0.000 0.504 0.496
T47.7 Emetics
0.000 0.504 0.496
T47.6 Antidiarrhoeal drugs
0.000 0.504 0.496
T47.5 Digestants
0.000 0.504 0.496
T47.4 Other laxatives
0.000 0.504 0.496
T47.3 Saline and osmotic laxatives
0.000 0.504 0.496
T47.2 Stimulant laxatives
0.000 0.504 0.496
T47.1 Other antacids and anti-gastric-secretion drugs
0.000 0.504 0.496
T47.0 Histamine H(2)-receptor antagonists
0.000 0.504 0.496
T48.7 Other and unspecified agents primarily acting on the respiratory system
0.000 0.504 0.496
T48.6 Antiasthmatics, not elsewhere classified
0.000 0.504 0.496
T48.5 Anti-common-cold drugs
0.000 0.504 0.496
T48.4 Expectorants
0.000 0.504 0.496
T48.3 Antitussives
0.000 0.504 0.496
T48.2 Other and unspecified agents primarily acting on muscles
0.000 0.504 0.496
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]
0.000 0.504 0.496
T48.0 Oxytocic drugs
0.000 0.504 0.496
T49.9 Topical agent, unspecified
0.000 0.504 0.496
T49.8 Other topical agents
0.000 0.504 0.496
T49.7 Dental drugs, topically applied
0.000 0.504 0.496
T49.6 Otorhinolaryngological drugs and preparations
0.000 0.504 0.496
T49.5 Ophthalmological drugs and preparations
0.000 0.504 0.496
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations
0.000 0.504 0.496
T49.3 Emollients, demulcents and protectants
0.000 0.504 0.496
T49.2 Local astringents and local detergents
0.000 0.504 0.496
T49.1 Antipruritics
0.000 0.504 0.496
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified
0.000 0.504 0.496
T50.7 Analeptics and opioid receptor antagonists
0.000 0.505 0.495
T50.6 Antidotes and chelating agents, not elsewhere classified
0.000 0.505 0.495
T50.5 Appetite depressants
0.000 0.505 0.495
T50.4 Drugs affecting uric acid metabolism
0.000 0.505 0.495
T50.3 Electrolytic, caloric and water-balance agents
0.000 0.505 0.495
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics
0.000 0.505 0.495
T50.1 Loop [high-ceiling] diuretics
0.000 0.505 0.495
T50.0 Mineralocorticoids and their antagonists
0.000 0.505 0.495
T38.1 Thyroid hormones and substitutes
0.000 0.536 0.464
T36.9 Systemic antibiotic, unspecified
0.000 0.551 0.449
T36.8 Other systemic antibiotics
0.000 0.551 0.449
T36.7 Antifungal antibiotics, systemically used
0.000 0.551 0.449
T36.6 Rifamycins
0.000 0.551 0.449
T36.5 Aminoglycosides
0.000 0.551 0.449
T36.4 Tetracyclines
0.000 0.551 0.449
T36.3 Macrolides
0.000 0.551 0.449
T36.2 Chloramphenicol group
0.000 0.551 0.449
T36.1 Cefalosporins and other Beta-lactam antibiotics
0.000 0.551 0.449
T50.8 Diagnostic agents
0.000 0.553 0.447
T45.0 Antiallergic and antiemetic drugs
0.000 0.567 0.433
T45.9 Primarily systemic and haematological agent, unspecified
0.000 0.592 0.408
T45.8 Other primarily systemic and haematological agents
0.000 0.592 0.408
T45.7 Anticoagulant antagonists, vitamin K and other coagulants
0.000 0.592 0.408
T45.6 Fibrinolysis-affecting drugs
0.000 0.592 0.408
T45.4 Iron and its compounds
0.000 0.592 0.408
T45.3 Enzymes, not elsewhere classified
0.000 0.592 0.408
T45.2 Vitamins, not elsewhere classified
0.000 0.610 0.390
T36.0 Penicillins
0.000 0.617 0.382
T45.1 Antineoplastic and immunosuppressive drugs
0.000 0.651 0.349
T45.5 Anticoagulants
0.000 0.651 0.349
D05.9 Carcinoma in situ of breast, unspecified
0.013 0.987 0.000
D05.1 Intraductal carcinoma in situ
0.012 0.988 0.000
D05 Carcinoma in situ of breast
0.012 0.988 0.000
D23.7 Skin of lower limb, including hip
0.000 0.991 0.009
D00-D09 In situ neoplasms
0.009 0.991 0.000
D05.0 Lobular carcinoma in situ
0.008 0.992 0.000
D04 Carcinoma in situ of skin
0.008 0.992 0.000
D04.5 Skin of trunk
0.008 0.992 0.000
D05.7 Other carcinoma in situ of breast
0.008 0.992 0.000
R94.3 Abnormal results of cardiovascular function studies
0.000 0.992 0.008
D01 Carcinoma in situ of other and unspecified digestive organs
0.008 0.992 0.000
D03 Melanoma in situ
0.008 0.992 0.000
D07 Carcinoma in situ of other and unspecified genital organs
0.008 0.992 0.000
N02.9 Unspecified
0.007 0.993 0.000
D01.0 Colon
0.007 0.993 0.000
D00 Carcinoma in situ of oral cavity, oesophagus and stomach
0.007 0.993 0.000
D04.1 Skin of eyelid, including canthus
0.007 0.993 0.000
D04.4 Skin of scalp and neck
0.007 0.993 0.000
Z95.0 Presence of cardiac pacemaker
0.000 0.993 0.007
D03.6 Melanoma in situ of upper limb, including shoulder
0.007 0.993 0.000
D04.2 Skin of ear and external auricular canal
0.006 0.994 0.000
D07.4 Penis
0.006 0.994 0.000
D07.2 Vagina
0.006 0.994 0.000
D03.3 Melanoma in situ of other and unspecified parts of face
0.006 0.994 0.000
D03.4 Melanoma in situ of scalp and neck
0.006 0.994 0.000
D04.9 Skin, unspecified
0.006 0.994 0.000
D04.8 Skin of other sites
0.006 0.994 0.000
D04.0 Skin of lip
0.006 0.994 0.000
K80.2 Calculus of gallbladder without cholecystitis
0.000 0.994 0.006
D04.3 Skin of other and unspecified parts of face
0.006 0.994 0.000
D03.2 Melanoma in situ of ear and external auricular canal
0.006 0.994 0.000
D01.9 Digestive organ, unspecified
0.006 0.994 0.000
D01.7 Other specified digestive organs
0.006 0.994 0.000
D01.5 Liver, gallbladder and bile ducts
0.006 0.994 0.000
D01.4 Other and unspecified parts of intestine
0.006 0.994 0.000
D01.3 Anus and anal canal
0.006 0.994 0.000
D01.2 Rectum
0.006 0.994 0.000
D01.1 Rectosigmoid junction
0.006 0.994 0.000
D03.9 Melanoma in situ, unspecified
0.006 0.994 0.000
D03.8 Melanoma in situ of other sites
0.006 0.994 0.000
D03.7 Melanoma in situ of lower limb, including hip
0.006 0.994 0.000
D03.1 Melanoma in situ of eyelid, including canthus
0.006 0.994 0.000
D03.0 Melanoma in situ of lip
0.006 0.994 0.000
D09 Carcinoma in situ of other and unspecified sites
0.006 0.994 0.000
D02 Carcinoma in situ of middle ear and respiratory system
0.006 0.994 0.000
D07.5 Prostate
0.006 0.994 0.000
D07.6 Other and unspecified male genital organs
0.006 0.994 0.000
D07.3 Other and unspecified female genital organs
0.006 0.994 0.000
D07.0 Endometrium
0.006 0.994 0.000
M47.82 Other spondylosis (Cervical region)
0.000 0.994 0.006
I69.4 Sequelae of stroke, not specified as haemorrhage or infarction
0.000 0.995 0.005
D07.1 Vulva
0.005 0.995 0.000
D04.7 Skin of lower limb, including hip
0.005 0.995 0.000
D00.0 Lip, oral cavity and pharynx
0.005 0.995 0.000
H21 Other disorders of iris and ciliary body
0.005 0.995 0.000
D00.2 Stomach
0.005 0.995 0.000
D00.1 Oesophagus
0.005 0.995 0.000
D06 Carcinoma in situ of cervix uteri
0.005 0.995 0.000
H15-H22 Disorders of sclera, cornea, iris and ciliary body
0.005 0.995 0.000
D03.5 Melanoma in situ of trunk
0.005 0.995 0.000
N02 Recurrent and persistent haematuria
0.005 0.995 0.000
G35 Multiple sclerosis
0.005 0.995 0.000
H16 Keratitis
0.005 0.995 0.000
H17 Corneal scars and opacities
0.005 0.995 0.000
H20 Iridocyclitis
0.005 0.995 0.000
H16.1 Other superficial keratitis without conjunctivitis
0.005 0.995 0.000
H21.5 Other adhesions and disruptions of iris and ciliary body
0.005 0.995 0.000
H17.9 Corneal scar and opacity, unspecified
0.005 0.995 0.000
D04.6 Skin of upper limb, including shoulder
0.004 0.995 0.000
D02.4 Respiratory system, unspecified
0.004 0.995 0.000
D02.3 Other parts of respiratory system
0.004 0.995 0.000
D02.2 Bronchus and lung
0.004 0.995 0.000
D02.1 Trachea
0.004 0.995 0.000
D09.9 Carcinoma in situ, unspecified
0.004 0.995 0.000
D09.7 Carcinoma in situ of other specified sites
0.004 0.995 0.000
D09.3 Thyroid and other endocrine glands
0.004 0.995 0.000
D09.2 Eye
0.004 0.995 0.000
D09.1 Other and unspecified urinary organs
0.004 0.995 0.000
H21.2 Degeneration of iris and ciliary body
0.004 0.995 0.000
H21.0 Hyphaema
0.004 0.995 0.000
H19 Disorders of sclera and cornea in diseases classified elsewhere
0.004 0.996 0.000
H16.3 Interstitial and deep keratitis
0.004 0.996 0.000
H21.8 Other specified disorders of iris and ciliary body
0.004 0.996 0.000
H20.8 Other iridocyclitis
0.004 0.996 0.000
N02.8 Other
0.004 0.996 0.000
H15 Disorders of sclera
0.004 0.996 0.000
H16.0 Corneal ulcer
0.004 0.996 0.000
N02.2 Diffuse membranous glomerulonephritis
0.004 0.996 0.000
H17.8 Other corneal scars and opacities
0.004 0.996 0.000
M10.90 Gout, unspecified (Multiple sites)
0.004 0.996 0.000
H21.9 Disorder of iris and ciliary body, unspecified
0.004 0.996 0.000
H21.4 Pupillary membranes
0.004 0.996 0.000
H21.3 Cyst of iris, ciliary body and anterior chamber
0.004 0.996 0.000
D06.7 Other parts of cervix
0.004 0.996 0.000
D06.1 Exocervix
0.004 0.996 0.000
D06.0 Endocervix
0.004 0.996 0.000
H20.9 Iridocyclitis, unspecified
0.004 0.996 0.000
H22 Disorders of iris and ciliary body in diseases classified elsewhere
0.004 0.996 0.000
N02.7 Diffuse crescentic glomerulonephritis
0.004 0.996 0.000
N02.6 Dense deposit disease
0.004 0.996 0.000
N02.5 Diffuse mesangiocapillary glomerulonephritis
0.004 0.996 0.000
N02.4 Diffuse endocapillary proliferative glomerulonephritis
0.004 0.996 0.000
N02.3 Diffuse mesangial proliferative glomerulonephritis
0.004 0.996 0.000
N02.1 Focal and segmental glomerular lesions
0.004 0.996 0.000
N02.0 Minor glomerular abnormality
0.004 0.996 0.000
H16.8 Other keratitis
0.004 0.996 0.000
H16.4 Corneal neovascularisation
0.004 0.996 0.000
H19.1 Herpesviral keratitis and keratoconjunctivitis
0.004 0.996 0.000
H17.1 Other central corneal opacity
0.004 0.996 0.000
H17.0 Adherent leukoma
0.004 0.996 0.000
H21.1 Other vascular disorders of iris and ciliary body
0.004 0.996 0.000
M47.80 Other spondylosis (Multiple sites in spine)
0.000 0.996 0.004
M47.8 Other spondylosis
0.000 0.996 0.004
H15.8 Other disorders of sclera
0.004 0.996 0.000
M24.27 Disorder of ligament (Ankle and foot)
0.004 0.996 0.000
D02.0 Larynx
0.003 0.996 0.000
H16.2 Keratoconjunctivitis
0.004 0.996 0.000
H20.2 Lens-induced iridocyclitis
0.003 0.996 0.000
H20.0 Acute and subacute iridocyclitis
0.004 0.996 0.000
M24.2 Disorder of ligament
0.004 0.996 0.000
G37 Other demyelinating diseases of central nervous system
0.004 0.996 0.000
D09.0 Bladder
0.003 0.996 0.000
M24.23 Disorder of ligament (Forearm)
0.004 0.996 0.000
I69.3 Sequelae of cerebral infarction
0.000 0.996 0.004
G37.9 Demyelinating disease of central nervous system, unspecified
0.003 0.996 0.000
H90.5 Sensorineural hearing loss, unspecified
0.004 0.996 0.000
I69 Sequelae of cerebrovascular disease
0.000 0.996 0.004
M50.3 Other cervical disk degeneration
0.000 0.996 0.004
G35-G37 Demyelinating diseases of the central nervous system
0.003 0.997 0.000
H19.8 Other disorders of sclera and cornea in diseases classified elsewhere
0.003 0.997 0.000
H19.3 Keratitis and keratoconjunctivitis in other diseases classified elsewhere
0.003 0.997 0.000
H19.2 Keratitis and keratoconjunctivitis in other infectious and parasitic diseases classified elsewhere
0.003 0.997 0.000
H19.0 Scleritis and episcleritis in diseases classified elsewhere
0.003 0.997 0.000
M13.96 Arthritis, unspecified (Lower leg)
0.003 0.997 0.000
H16.9 Keratitis, unspecified
0.003 0.997 0.000
H15.9 Disorder of sclera, unspecified
0.003 0.997 0.000
H15.0 Scleritis
0.003 0.997 0.000
G37.3 Acute transverse myelitis in demyelinating disease of central nervous system
0.003 0.997 0.000
H20.1 Chronic iridocyclitis
0.003 0.997 0.000
H15.1 Episcleritis
0.003 0.997 0.000
R47.1 Dysarthria and anarthria
0.003 0.997 0.000
M47.87 Other spondylosis (Lumbosacral region)
0.000 0.997 0.003
M47.88 Other spondylosis (Sacral and sacrococcygeal region)
0.000 0.997 0.003
M24.24 Disorder of ligament (Hand)
0.003 0.997 0.000
H18 Other disorders of cornea
0.003 0.997 0.000
H22.8 Other disorders of iris and ciliary body in diseases classified elsewhere
0.003 0.997 0.000
H22.1 Iridocyclitis in other diseases classified elsewhere
0.003 0.997 0.000
H22.0 Iridocyclitis in infectious and parasitic diseases classified elsewhere
0.003 0.997 0.000
I08.0 Disorders of both mitral and aortic valves
0.003 0.997 0.000
M47.85 Other spondylosis (Thoracolumbar region)
0.000 0.997 0.003
M47.84 Other spondylosis (Thoracic region)
0.000 0.997 0.003
M47.83 Other spondylosis (Cervicothoracic region)
0.000 0.997 0.003
M47.81 Other spondylosis (Occipito-atlanto-axial region)
0.000 0.997 0.003
R18 Ascites
0.003 0.997 0.000
M89.0 Algoneurodystrophy
0.003 0.997 0.000
M13.95 Arthritis, unspecified (Pelvic region and thigh)
0.003 0.997 0.000
M10.96 Gout, unspecified (Lower leg)
0.003 0.997 0.000
M89.06 Algoneurodystrophy (Lower leg)
0.003 0.997 0.000
C50.2 Upper-inner quadrant of breast
0.000 0.997 0.003
G37.8 Other specified demyelinating diseases of central nervous system
0.003 0.997 0.000
G37.5 Concentric sclerosis [Balo]
0.003 0.997 0.000
G37.4 Subacute necrotising myelitis
0.003 0.997 0.000
G37.2 Central pontine myelinolysis
0.003 0.997 0.000
G37.1 Central demyelination of corpus callosum
0.003 0.997 0.000
G37.0 Diffuse sclerosis
0.003 0.997 0.000
M24.29 Disorder of ligament (Site unspecified)
0.003 0.997 0.000
M24.28 Disorder of ligament (Other)
0.003 0.997 0.000
M24.25 Disorder of ligament (Pelvic region and thigh)
0.003 0.997 0.000
M24.22 Disorder of ligament (Upper arm)
0.003 0.997 0.000
M24.21 Disorder of ligament (Shoulder region)
0.003 0.997 0.000
M24.20 Disorder of ligament (Multiple sites)
0.003 0.997 0.000
M89.04 Algoneurodystrophy (Hand)
0.003 0.997 0.000
I69.1 Sequelae of intracerebral haemorrhage
0.000 0.997 0.003
Z45.0 Adjustment and management of cardiac pacemaker
0.000 0.997 0.003
M24.26 Disorder of ligament (Lower leg)
0.003 0.997 0.000
M89.03 Algoneurodystrophy (Forearm)
0.003 0.997 0.000
G36 Other acute disseminated demyelination
0.003 0.997 0.000
B37.3 Candidiasis of vulva and vagina
0.003 0.997 0.000
M10.9 Gout, unspecified
0.003 0.997 0.000
I69.2 Sequelae of other nontraumatic intracranial haemorrhage
0.000 0.997 0.003
H18.8 Other specified disorders of cornea
0.003 0.997 0.000
I69.0 Sequelae of subarachnoid haemorrhage
0.000 0.997 0.003
Z45.8 Adjustment and management of other implanted devices
0.000 0.997 0.003
H18.1 Bullous keratopathy
0.003 0.997 0.000
M10.94 Gout, unspecified (Hand)
0.003 0.997 0.000
H18.2 Other corneal oedema
0.003 0.997 0.000
A49.0 Staphylococcal infection, unspecified
0.000 0.997 0.003
H90.3 Sensorineural hearing loss, bilateral
0.003 0.997 0.000
N89.5 Stricture and atresia of vagina
0.003 0.997 0.000
X62.9 Unspecified place
0.000 0.997 0.003
M24 Other specific joint derangements
0.003 0.997 0.000
M89.07 Algoneurodystrophy (Ankle and foot)
0.003 0.997 0.000
H90 Conductive and sensorineural hearing loss
0.003 0.997 0.000
H18.5 Hereditary corneal dystrophies
0.003 0.997 0.000
I69.8 Sequelae of other and unspecified cerebrovascular diseases
0.000 0.997 0.002
H18.7 Other corneal deformities
0.002 0.997 0.000
H18.3 Changes in corneal membranes
0.002 0.997 0.000
H18.0 Corneal pigmentations and deposits
0.002 0.997 0.000
M24.17 Other articular cartilage disorders (Ankle and foot)
0.002 0.997 0.000
N41.9 Inflammatory disease of prostate, unspecified
0.000 0.997 0.003
M47.89 Other spondylosis (Site unspecified)
0.000 0.997 0.002
M24.1 Other articular cartilage disorders
0.002 0.997 0.000
X41.9 Unspecified place
0.000 0.998 0.002
Z22.3 Carrier of other specified bacterial diseases
0.002 0.998 0.000
M24.5 Contracture of joint
0.002 0.998 0.000
M47.86 Other spondylosis (Lumbar region)
0.000 0.998 0.002
M89.09 Algoneurodystrophy (Site unspecified)
0.002 0.998 0.000
M89.08 Algoneurodystrophy (Other)
0.002 0.998 0.000
M89.05 Algoneurodystrophy (Pelvic region and thigh)
0.002 0.998 0.000
M89.02 Algoneurodystrophy (Upper arm)
0.002 0.998 0.000
M89.01 Algoneurodystrophy (Shoulder region)
0.002 0.998 0.000
M89.00 Algoneurodystrophy (Multiple sites)
0.002 0.998 0.000
M24.6 Ankylosis of joint
0.002 0.998 0.000
B37.0 Candidal stomatitis
0.002 0.998 0.000
D06.9 Cervix, unspecified
0.002 0.998 0.000
M24.13 Other articular cartilage disorders (Forearm)
0.002 0.998 0.000
B44.1 Other pulmonary aspergillosis
0.002 0.998 0.000
M24.8 Other specific joint derangements, not elsewhere classified
0.002 0.998 0.000
H18.4 Corneal degeneration
0.002 0.998 0.000
R47.0 Dysphasia and aphasia
0.002 0.998 0.000
G36.9 Acute disseminated demyelination, unspecified
0.002 0.998 0.000
G36.8 Other specified acute disseminated demyelination
0.002 0.998 0.000
G36.1 Acute and subacute haemorrhagic leukoencephalitis [Hurst]
0.002 0.998 0.000
G36.0 Neuromyelitis optica [Devic]
0.002 0.998 0.000
K70.3 Alcoholic cirrhosis of liver
0.002 0.998 0.000
R47 Speech disturbances, not elsewhere classified
0.002 0.998 0.000
M24.67 Ankylosis of joint (Ankle and foot)
0.002 0.998 0.000
H90.8 Mixed conductive and sensorineural hearing loss, unspecified
0.002 0.998 0.000
M10.98 Gout, unspecified (Other)
0.002 0.998 0.000
M10.95 Gout, unspecified (Pelvic region and thigh)
0.002 0.998 0.000
M10.93 Gout, unspecified (Forearm)
0.002 0.998 0.000
M10.92 Gout, unspecified (Upper arm)
0.002 0.998 0.000
M10.91 Gout, unspecified (Shoulder region)
0.002 0.998 0.000
Z83.5 Family history of eye and ear disorders
0.000 0.998 0.002
M24.56 Contracture of joint (Lower leg)
0.002 0.998 0.000
D75.1 Secondary polycythaemia
0.000 0.998 0.002
M24.57 Contracture of joint (Ankle and foot)
0.002 0.998 0.000
M24.9 Joint derangement, unspecified
0.002 0.998 0.000
M24.7 Protrusio acetabuli
0.002 0.998 0.000
G56.2 Lesion of ulnar nerve
0.000 0.998 0.002
H90.7 Mixed conductive and sensorineural hearing loss, unilateral with unrestricted hearing on the contralateral side
0.002 0.998 0.000
H90.1 Conductive hearing loss, unilateral with unrestricted hearing on the contralateral side
0.002 0.998 0.000
B37 Candidiasis
0.002 0.998 0.000
H18.6 Keratoconus
0.002 0.998 0.000
R59.1 Generalised enlarged lymph nodes
0.002 0.998 0.000
M24.84 Other specific joint derangements, not elsewhere classified (Hand)
0.002 0.998 0.000
H90.0 Conductive hearing loss, bilateral
0.002 0.998 0.000
M24.19 Other articular cartilage disorders (Site unspecified)
0.002 0.998 0.000
M24.18 Other articular cartilage disorders (Other)
0.002 0.998 0.000
M24.14 Other articular cartilage disorders (Hand)
0.002 0.998 0.000
M24.12 Other articular cartilage disorders (Upper arm)
0.002 0.998 0.000
M24.10 Other articular cartilage disorders (Multiple sites)
0.002 0.998 0.000
H90.6 Mixed conductive and sensorineural hearing loss, bilateral
0.002 0.998 0.000
Z86.0 Personal history of other neoplasms
0.002 0.998 0.000
M24.51 Contracture of joint (Shoulder region)
0.002 0.998 0.000
H90.4 Sensorineural hearing loss, unilateral with unrestricted hearing on the contralateral side
0.002 0.998 0.000
M24.3 Pathological dislocation and subluxation of joint, not elsewhere classified
0.002 0.998 0.000
M24.0 Loose body in joint
0.002 0.998 0.000
M24.85 Other specific joint derangements, not elsewhere classified (Pelvic region and thigh)
0.002 0.998 0.000
G96.0 Cerebrospinal fluid leak
0.002 0.998 0.000
H11.0 Pterygium
0.002 0.998 0.000
M24.07 Loose body in joint (Ankle and foot)
0.002 0.998 0.000
M24.59 Contracture of joint (Site unspecified)
0.002 0.998 0.000
M24.58 Contracture of joint (Other)
0.002 0.998 0.000
M24.55 Contracture of joint (Pelvic region and thigh)
0.002 0.998 0.000
M24.53 Contracture of joint (Forearm)
0.002 0.998 0.000
M24.52 Contracture of joint (Upper arm)
0.002 0.998 0.000
M24.50 Contracture of joint (Multiple sites)
0.002 0.998 0.000
B37.4 Candidiasis of other urogenital sites
0.002 0.998 0.000
M24.69 Ankylosis of joint (Site unspecified)
0.002 0.998 0.000
M24.68 Ankylosis of joint (Other)
0.002 0.998 0.000
M24.66 Ankylosis of joint (Lower leg)
0.002 0.998 0.000
M24.65 Ankylosis of joint (Pelvic region and thigh)
0.002 0.998 0.000
M24.64 Ankylosis of joint (Hand)
0.002 0.998 0.000
M24.63 Ankylosis of joint (Forearm)
0.002 0.998 0.000
M24.62 Ankylosis of joint (Upper arm)
0.002 0.998 0.000
M24.61 Ankylosis of joint (Shoulder region)
0.002 0.998 0.000
M24.60 Ankylosis of joint (Multiple sites)
0.002 0.998 0.000
M24.81 Other specific joint derangements, not elsewhere classified (Shoulder region)
0.002 0.998 0.000
B37.2 Candidiasis of skin and nail
0.002 0.998 0.000
M24.16 Other articular cartilage disorders (Lower leg)
0.002 0.998 0.000
D13.2 Duodenum
0.000 0.998 0.002
M24.15 Other articular cartilage disorders (Pelvic region and thigh)
0.002 0.998 0.000
M24.89 Other specific joint derangements, not elsewhere classified (Site unspecified)
0.002 0.998 0.000
M24.88 Other specific joint derangements, not elsewhere classified (Other)
0.002 0.998 0.000
M24.87 Other specific joint derangements, not elsewhere classified (Ankle and foot)
0.002 0.998 0.000
M24.83 Other specific joint derangements, not elsewhere classified (Forearm)
0.002 0.998 0.000
M24.82 Other specific joint derangements, not elsewhere classified (Upper arm)
0.002 0.998 0.000
M24.80 Other specific joint derangements, not elsewhere classified (Multiple sites)
0.002 0.998 0.000
H18.9 Disorder of cornea, unspecified
0.002 0.998 0.000
M24.54 Contracture of joint (Hand)
0.002 0.998 0.000
H90.2 Conductive hearing loss, unspecified
0.002 0.998 0.000
B44 Aspergillosis
0.002 0.998 0.000
M89 Other disorders of bone
0.002 0.998 0.000
M24.4 Recurrent dislocation and subluxation of joint
0.002 0.998 0.000
Z99.2 Dependence on renal dialysis
0.000 0.998 0.002
K50.1 Crohn's disease of large intestine
0.002 0.998 0.000
M13.93 Arthritis, unspecified (Forearm)
0.002 0.998 0.000
M24.79 Protrusio acetabuli-Site unspec
0.002 0.998 0.000
M24.78 Protrusio acetabuli-Other
0.002 0.998 0.000
M24.77 Protrusio acetabuli-Ankle/foot
0.002 0.998 0.000
M24.76 Protrusio acetabuli-Lower leg
0.002 0.998 0.000
M24.75 Protrusio acetabuli-Pelvic/thigh
0.002 0.998 0.000
M24.74 Protrusio acetabuli-Hand
0.002 0.998 0.000
M24.73 Protrusio acetabuli-Forearm
0.002 0.998 0.000
M24.72 Protrusio acetabuli-Upper arm
0.002 0.998 0.000
M24.71 Protrusio acetabuli-Shldr region
0.002 0.998 0.000
M24.70 Protrusio acetabuli-Mult sites
0.002 0.998 0.000
M24.99 Joint derangement, unspecified (Site unspecified)
0.002 0.998 0.000
M24.98 Joint derangement, unspecified (Other)
0.002 0.998 0.000
M24.97 Joint derangement, unspecified (Ankle and foot)
0.002 0.998 0.000
M24.96 Joint derangement, unspecified (Lower leg)
0.002 0.998 0.000
M24.95 Joint derangement, unspecified (Pelvic region and thigh)
0.002 0.998 0.000
M24.94 Joint derangement, unspecified (Hand)
0.002 0.998 0.000
M24.93 Joint derangement, unspecified (Forearm)
0.002 0.998 0.000
M24.92 Joint derangement, unspecified (Upper arm)
0.002 0.998 0.000
M24.91 Joint derangement, unspecified (Shoulder region)
0.002 0.998 0.000
M24.90 Joint derangement, unspecified (Multiple sites)
0.002 0.998 0.000
S62.30 Fracture of other metacarpal bone (closed)
0.002 0.998 0.000
Z45 Adjustment and management of implanted device
0.000 0.998 0.002
B37.7 Candidal septicaemia
0.002 0.998 0.000
B37.6 Candidal endocarditis
0.002 0.998 0.000
B37.5 Candidal meningitis
0.002 0.998 0.000
I08.2 Disorders of both aortic and tricuspid valves
0.002 0.998 0.000
M24.11 Other articular cartilage disorders (Shoulder region)
0.002 0.998 0.000
M24.86 Other specific joint derangements, not elsewhere classified (Lower leg)
0.002 0.998 0.000
M24.09 Loose body in joint (Site unspecified)
0.002 0.998 0.000
M24.08 Loose body in joint (Other)
0.002 0.998 0.000
M24.06 Loose body in joint-Lower leg
0.002 0.998 0.000
M24.05 Loose body in joint (Pelvic region and thigh)
0.002 0.998 0.000
M24.04 Loose body in joint (Hand)
0.002 0.998 0.000
M24.03 Loose body in joint (Forearm)
0.002 0.998 0.000
M24.00 Loose body in joint (Multiple sites)
0.002 0.998 0.000
M24.39 Pathological dislocation and subluxation of joint, not elsewhere classified (Site unspecified)
0.001 0.998 0.000
M24.38 Pathological dislocation and subluxation of joint, not elsewhere classified (Other)
0.001 0.998 0.000
M24.36 Pathological dislocation and subluxation of joint, not elsewhere classified (Lower leg)
0.001 0.998 0.000
M24.35 Pathological dislocation and subluxation of joint, not elsewhere classified (Pelvic region and thigh)
0.001 0.998 0.000
M24.34 Pathological dislocation and subluxation of joint, not elsewhere classified (Hand)
0.001 0.998 0.000
M24.33 Pathological dislocation and subluxation of joint, not elsewhere classified (Forearm)
0.001 0.998 0.000
M24.32 Pathological dislocation and subluxation of joint, not elsewhere classified (Upper arm)
0.001 0.998 0.000
M24.31 Pathological dislocation and subluxation of joint, not elsewhere classified (Shoulder region)
0.001 0.998 0.000
M24.30 Pathological dislocation and subluxation of joint, not elsewhere classified (Multiple sites)
0.001 0.998 0.000
L50.9 Urticaria, unspecified
0.002 0.998 0.000
L72.0 Epidermal cyst
0.000 0.998 0.002
M86.96 Osteomyelitis, unspecified (Lower leg)
0.002 0.998 0.000
N90.8 Other specified noninflammatory disorders of vulva and perineum
0.000 0.998 0.002
O71.8 Other specified obstetric trauma
0.002 0.998 0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

 

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

This website was created, designed, and edited by ORCID iD iconPatrick K. Albers

The contents of TreeWAS.org are available under the Creative Commons Attribution 4.0 International License (CC BY 4.0) with attribution (citation) required.

TreeWAS Database © 2019 - 2024 About Frequently Asked Questions Citation Contact Terms & Conditions This website does not use cookies to collect any personal information about you.